Clinical trial
A Randomized Controlled, Open-Label, Rater-Blinded Pragmatic Trial, Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
NCT07100990 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled, Open-Label, Rater-Blinded Pragmatic Trial, Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- July 11, 2025
- Completion date
- April 30, 2031
- Enrollment
- 382 (estimated)
- Sites
- 35
Conditions
As the registry lists them; a condition with its own page is linked.